S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.08%) $0.927
USD/NOK
(0.28%) $10.87
USD/GBP
(0.07%) $0.793
USD/RUB
(-0.32%) $92.28

Realtime updates for Towa Pharmaceutical Co., [4553.T]

Exchange: JPX Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Last Updated29 Mar 2024 @ 02:15

-0.89% ¥ 2 904.00

Live Chart Being Loaded With Signals

Commentary (29 Mar 2024 @ 02:15):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan...

Stats
Today's Volume 162 000
Average Volume 189 364
Market Cap 142.93B
EPS ¥0 ( 2024-02-12 )
Next earnings date ( ¥38.66 ) 2024-05-12
Last Dividend ¥30.00 ( 2023-03-30 )
Next Dividend ¥0 ( N/A )
P/E 12.18
ATR14 ¥1.903 (0.07%)

Volume Correlation

Long: 0.34 (neutral)
Short: -0.12 (neutral)
Signal:(58.901) Neutral

Towa Pharmaceutical Co., Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Towa Pharmaceutical Co., Correlation - Currency/Commodity

The country flag -0.40
( neutral )
The country flag 0.06
( neutral )
The country flag -0.39
( neutral )
The country flag -0.41
( neutral )
The country flag -0.39
( neutral )
The country flag 0.20
( neutral )

Towa Pharmaceutical Co., Financials

Annual 2022
Revenue: ¥208.86B
Gross Profit: ¥72.71B (34.81 %)
EPS: ¥44.72
Q3 2023
Revenue: ¥60.93B
Gross Profit: ¥22.17B (36.38 %)
EPS: ¥92.75
Q2 2023
Revenue: ¥52.85B
Gross Profit: ¥18.23B (34.50 %)
EPS: ¥44.76
Q1 2023
Revenue: ¥54.55B
Gross Profit: ¥20.01B (36.68 %)
EPS: ¥96.50

Financial Reports:

No articles found.

Towa Pharmaceutical Co., Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥30.00
(N/A)
¥0
(N/A)
¥30.00
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)

Towa Pharmaceutical Co., Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.24 - good (92.41%) | Divividend Growth Potential Score: 4.04 - Stable (19.23%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend ¥1.667 2005-03-28
Last Dividend ¥30.00 2023-03-30
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 38 --
Total Paid Out ¥541.50 --
Avg. Dividend % Per Year 0.00% --
Score 3.37 --
Div. Sustainability Score 9.24
Div.Growth Potential Score 4.04
Div. Directional Score 6.64 --
Next Divdend (Est)
(2024-07-03)
¥0 Estimate 3.75 %
Dividend Stability
0.30 Poor
Dividend Score
3.37
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
9369.T Ex Dividend Junior 2023-11-29 Semi-Annually 0 0.00%
8367.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
7803.T Ex Dividend Junior 2024-06-27 Annually 0 0.00%
6981.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
6368.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
5332.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
4398.T Ex Dividend Knight 2023-12-28 Semi-Annually 0 0.00%
3591.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
2813.T Ex Dividend Knight 2024-03-28 Annually 0 0.00%
1515.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.04961.5009.0110.00[0 - 0.5]
returnOnAssetsTTM0.02831.2009.0610.00[0 - 0.3]
returnOnEquityTTM0.08141.500-0.207-0.310[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.770.8001.1480.919[1 - 3]
quickRatioTTM1.1730.8007.816.25[0.8 - 2.5]
cashRatioTTM0.3991.5008.8910.00[0.2 - 2]
debtRatioTTM0.473-1.5002.12-3.17[0 - 0.6]
interestCoverageTTM16.441.0005.025.02[3 - 30]
operatingCashFlowPerShareTTM821.312.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM821.312.0010.0010.00[0 - 20]
debtEquityRatioTTM1.318-1.5004.73-7.09[0 - 2.5]
grossProfitMarginTTM0.3471.0007.567.56[0.2 - 0.8]
operatingProfitMarginTTM0.05641.000-0.871-0.871[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2061.0009.979.97[0.2 - 2]
assetTurnoverTTM0.5710.8009.537.62[0.5 - 2]
Total Score9.24

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM12.061.0008.880[1 - 100]
returnOnEquityTTM0.08142.50-0.133-0.310[0.1 - 1.5]
freeCashFlowPerShareTTM821.312.0010.0010.00[0 - 30]
dividendYielPercentageTTM3.131.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM821.312.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.1401.500-4.270[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1711.0008.230[0.1 - 0.5]
Total Score4.04

Towa Pharmaceutical Co.,

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators